Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 238 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances.
Kumar AR, Nair B, Kamath AJ, Nath LR, Calina D, Sharifi-Rad J
Eur J Med Res, 29(1):485, 05 Oct 2024
Cited by: 0 articles | PMID: 39367507 | PMCID: PMC11453073
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future.
Noor S, Ali S, Summer M, Riaz A, Nazakat L, Aqsa
Probiotics Antimicrob Proteins, 24 Sep 2024
Cited by: 0 articles | PMID: 39316257
Add to export list Review
Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice.
Panyod S, Wu WK, Hsieh YC, Tseng YJ, Peng SY, Chen RA, Huang HS, Chen YH, Shen TD, Ho CT, Liu CJ, Chuang HL, Huang CC, Wu MS, Sheen LY
Nutr Diabetes, 14(1):65, 16 Aug 2024
Cited by: 2 articles | PMID: 39152116 | PMCID: PMC11329514
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.
Schophaus S, Creasy KT, Koop PH, Clusmann J, Jaeger J, Punnuru V, Koch A, Trautwein C, Loomba R, Luedde T, Schneider KM, Schneider CV
Liver Int, 44(10):2807-2821, 31 Jul 2024
Cited by: 0 articles | PMID: 39082383
Add to export list
Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota-Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal.
Sánchez-Tapia M, Tobón-Cornejo S, Noriega LG, Vázquez-Manjarrez N, Coutiño-Hernández D, Granados-Portillo O, Román-Calleja BM, Ruíz-Margáin A, Macías-Rodríguez RU, Tovar AR, Torres N
Nutrients, 16(16):2594, 06 Aug 2024
Cited by: 0 articles | PMID: 39203731 | PMCID: PMC11357552
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Fogacci F, Giovannini M, Di Micoli V, Grandi E, Borghi C, Cicero AFG
Nutrients, 16(15):2454, 28 Jul 2024
Cited by: 0 articles | PMID: 39125336 | PMCID: PMC11313833
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis.
Alam N, Jia L, Cheng A, Ren H, Fu Y, Ding X, Haq IU, Liu E
Front Pharmacol, 15:1390483, 11 Jul 2024
Cited by: 3 articles | PMID: 39070791 | PMCID: PMC11273336
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment.
Zhang R, Yan Z, Zhong H, Luo R, Liu W, Xiong S, Liu Q, Liu M
Hepatol Commun, 8(7):e0484, 05 Jul 2024
Cited by: 1 article | PMID: 38967596 | PMCID: PMC11227362
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.
Maddineni G, Obulareddy SJ, Paladiya RD, Korsapati RR, Jain S, Jeanty H, Vikash F, Tummala NC, Shetty S, Ghazalgoo A, Mahapatro A, Polana V, Patel D
Ann Med Surg (Lond), 86(8):4714-4731, 20 Jun 2024
Cited by: 0 articles | PMID: 39118769 | PMCID: PMC11305784
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2.
Klag KA, Bell R, Jia X, Seguin A, Maschek JA, Bronner M, Cox JE, Round JL, Ward DM
Nutrients, 16(12):1804, 08 Jun 2024
Cited by: 0 articles | PMID: 38931165
Add to export list
Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials-A Narrative Review.
Ziółkiewicz A, Niziński P, Soja J, Oniszczuk T, Combrzyński M, Kondracka A, Oniszczuk A
Metabolites, 14(6):346, 20 Jun 2024
Cited by: 0 articles | PMID: 38921480 | PMCID: PMC11205996
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Spirulina (Arthrospira platensis) Improved Nonalcoholic Fatty Liver Disease Characteristics and Microbiota and Did Not Affect Organ Fibrosis Induced by a Fructose-Enriched Diet in Wistar Male Rats.
Fakhoury-Sayegh N, Hamdan A, Lebbos S, Itani T, Trak-Smayra V, Khazzaka A, Dagher-Hamalian C, Sayegh LN, Mallah M, Obeid O, Sayegh R
Nutrients, 16(11):1701, 30 May 2024
Cited by: 0 articles | PMID: 38892633 | PMCID: PMC11174493
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions.
Wei M, Tu W, Huang G
Front Microbiol, 15:1341938, 03 Jun 2024
Cited by: 0 articles | PMID: 38887706 | PMCID: PMC11180741
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial.
Mantri A, Köhlmoos A, Schelski DS, Seel W, Stoffel-Wagner B, Krawitz P, Stehle P, Holst JJ, Weber B, Koban L, Plassmann H, Simon MC
Nutrients, 16(9):1300, 26 Apr 2024
Cited by: 0 articles | PMID: 38732547 | PMCID: PMC11085762
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The footprint of gut microbiota in gallbladder cancer: a mechanistic review.
Liu S, Li W, Chen J, Li M, Geng Y, Liu Y, Wu W
Front Cell Infect Microbiol, 14:1374238, 07 May 2024
Cited by: 3 articles | PMID: 38774627 | PMCID: PMC11106419
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Associations of Ultrasound Findings with Serum Iron and Ferritin Levels in Children with Obesity.
Stepan MD, Vintilescu ȘB, Ionele CM, Dumitra GG, Podeanu MA, Bigea CC, Sacerdoțianu VM, Anastasescu CM, Florescu DN
Life (Basel), 14(4):484, 07 Apr 2024
Cited by: 0 articles | PMID: 38672754 | PMCID: PMC11051232
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review.
Deng J, Qin L, Qin S, Wu R, Huang G, Fang Y, Huang L, Zhou Z
J Inflamm Res, 17:2073-2088, 03 Apr 2024
Cited by: 0 articles | PMID: 38585470 | PMCID: PMC10999193
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis.
Dobbie LJ, Burgess J, Hamid A, Nevitt SJ, Hydes TJ, Alam U, Cuthbertson DJ
Nutrients, 16(7):1030, 01 Apr 2024
Cited by: 4 articles | PMID: 38613063 | PMCID: PMC11013586
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Bacteroides and NAFLD: pathophysiology and therapy.
Zhang J, Zhou J, He Z, Li H
Front Microbiol, 15:1288856, 20 Mar 2024
Cited by: 1 article | PMID: 38572244 | PMCID: PMC10988783
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment.
Savari F, Mard SA
Heliyon, 10(7):e28468, 25 Mar 2024
Cited by: 0 articles | PMID: 38689985 | PMCID: PMC11059522
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults.
Zeng F, Su X, Liang X, Liao M, Zhong H, Xu J, Gou W, Zhang X, Shen L, Zheng JS, Chen YM
BMC Med, 22(1):104, 07 Mar 2024
Cited by: 3 articles | PMID: 38454425
Add to export list
Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice.
Wyss J, Raselli T, Wyss A, Telzerow A, Rogler G, Krupka N, Yilmaz B, Schmidt TSB, Misselwitz B
BMC Microbiol, 24(1):69, 28 Feb 2024
Cited by: 0 articles | PMID: 38418983 | PMCID: PMC10900623
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics.
Nicastro E, D'Antiga L
Adv Exp Med Biol, 1449:113-133, 01 Jan 2024
Cited by: 1 article | PMID: 39060734
Add to export list Review
The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies.
Hizo GH, Rampelotto PH
Microorganisms, 11(12):2999, 17 Dec 2023
Cited by: 3 articles | PMID: 38138143 | PMCID: PMC10745637
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends.
Pezzino S, Sofia M, Mazzone C, Litrico G, Agosta M, La Greca G, Latteri S
Sci Rep, 14(1):799, 08 Jan 2024
Cited by: 1 article | PMID: 38191502 | PMCID: PMC10774379
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 238 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances.

Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future.

Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice.

Machine learning uncovers manganese as a key nutrient associated with reduced risk of steatotic liver disease.

Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota-Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal.

Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis.

Gut microbial metabolites in MASLD: Implications of mitochondrial dysfunction in the pathogenesis and treatment.

The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.

Low-Iron Diet-Induced Fatty Liver Development Is Microbiota Dependent and Exacerbated by Loss of the Mitochondrial Iron Importer Mitoferrin2.

Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials-A Narrative Review.

Spirulina (Arthrospira platensis) Improved Nonalcoholic Fatty Liver Disease Characteristics and Microbiota and Did Not Affect Organ Fibrosis Induced by a Fructose-Enriched Diet in Wistar Male Rats.

Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions.

Impact of Synbiotic Intake on Liver Metabolism in Metabolically Healthy Participants and Its Potential Preventive Effect on Metabolic-Dysfunction-Associated Fatty Liver Disease (MAFLD): A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial.

The footprint of gut microbiota in gallbladder cancer: a mechanistic review.

Associations of Ultrasound Findings with Serum Iron and Ferritin Levels in Children with Obesity.

NcRNA Regulated Pyroptosis in Liver Diseases and Traditional Chinese Medicine Intervention: A Narrative Review.

Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis.

Bacteroides and NAFLD: pathophysiology and therapy.

Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment.

Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults.

Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice.

Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics.

The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies.

Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends.

Partnerships & funding